Clinical Trial Update: Epcoritamab-CAR T Cells for Large B-cell Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating epcoritamab-CAR T cells for large B-cell lymphomas, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• High-grade B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• epcoritamab-CAR T cells

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Lymphoma, Non-Hodgkin, Relapsed Diffuse Large B Cell Lymphoma | Phase 2 | Status: RECRUITING